igf-1 lr3 timing post-workout in Aesthetic and Anti-Aging Medicine: Benefits and Risks Switched things up and have – igf 1 lr3 injection time

Evidence Limitations and Unanswered Questions The main evidence limitations for GHK-Cu are uneven human data, formulation differences, limited injectable safety information, small topical skin studies, indirect hair evidence, and uncertain long-term outcomes [2], [6], [7], [8]

Growth hormone production begins declining around age 30, with roughly 15% reduction per decade thereafter

So far, most of this data comes from animal studies or early-phase research, not large human trials

Medi-Peel products do exactly that

Published 2018 Jul 7

IV therapy should only be performed by qualified medical professionals in a licensed clinical setting after a proper consultation